Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model.

Sheehan JP, Sheehan JM, Seeherman H, Quigg M, Helm GA.

J Neurosurg. 2003 Jan;98(1):125-30.

PMID:
12546360
2.

Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Poynton AR, Lane JM.

Spine (Phila Pa 1976). 2002 Aug 15;27(16 Suppl 1):S40-8. Review.

PMID:
12205419
3.

A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft).

McKay WF, Peckham SM, Badura JM.

Int Orthop. 2007 Dec;31(6):729-34. Review.

4.

Immunogenicity of bone morphogenetic proteins.

Hwang CJ, Vaccaro AR, Lawrence JP, Hong J, Schellekens H, Alaoui-Ismaili MH, Falb D.

J Neurosurg Spine. 2009 May;10(5):443-51. doi: 10.3171/2009.1.SPINE08473. Review.

PMID:
19442006
5.

A review of preclinical program development for evaluating injectable carriers for osteogenic factors.

Seeherman H, Li R, Wozney J.

J Bone Joint Surg Am. 2003;85-A Suppl 3:96-108. Review. No abstract available.

PMID:
12925616

Supplemental Content

Support Center